CAY10510

CAY10510 （订货以CAS编码或英文名称为准）

Product Type|Biochemicals|Lipids|Prostaglandins||Product Type|Biochemicals|Receptor Pharmacology|Agonists||Research Area|Lipid Biochemistry|Cyclooxygenase Pathway

创赛科技提供的所有产品仅用于科研等非医疗用途，非药品不可食用，不可用于人体或动物的临床诊断和治疗,我们不为个人提供产品及服务。如您需要产品COA等资料，可至下方“质量控制”中下载

编号：PC54209

分子式：C33H33CAF2N2O5

CAS号：291303-34-9

分子量：615.70

储存条件：-20℃

申请试用

货号	品牌	规格	纯度/含量	标准价	优惠价
PC54209-10mg	Medlife	10mg	≥95%	待询	登录后可见
PC54209-20mg	Medlife	20mg	≥95%	待询	登录后可见
PC54209-50mg	Medlife	50mg	≥95%	待询	登录后可见
PC54209-100mg	Medlife	100mg	≥95%	待询	登录后可见
PC54209-500µg	Medlife	EA		¥1045.00	登录后可见
PC54209-100µg	Medlife	EA		¥331.00	登录后可见
PC54209-1mg	Medlife	EA		¥1913.00	登录后可见
PC54209-5mg	Medlife	EA		¥7919.00	登录后可见

中文名称：	二氟阿托伐他汀钙
中文别名：	二氟阿托伐他汀钙;阿托伐他汀钙杂质III;阿托伐他汀;阿托伐他汀钙杂质 C （[R-(3R,5R)]-β,δ-二羟基-5-（1-甲基乙基）-2,3-二（4-氟苯基）-4-[(苯胺基)羰基]-1H-吡咯-1-庚酸钙盐（2：1））;阿托伐他汀钙杂质C;阿托伐他汀相关物质C USP标准品;阿托伐他汀杂质C;阿托伐他汀相关物质C
英文名称：	CAY10510
英文别名：	Atorvastatin Calcium Difluoro impurity;Difluoro Atorvastatin Calcium Salt;ATORVASTATIN EP IMPURITY C (SODIUM SALT);Atorvastatin Related Compound C;Atorvastatin EP Imp C;Difluoro iMpurity, or (3R,5R)-7-[3-(phenylcarbaMoyl)-4,5-bis(4-fluorophenyl)-2-isopropyl-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid calciuM salt;(βR,δR)-2,3-Bis(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid hemicalcium salt;Atorvastatin Impurity-C;CID 131632040
CAS号：	291303-34-9
分子式：	C33H33CAF2N2O5
分子量：	615.70
详细描述	Product Type\|Biochemicals\|Lipids\|Prostaglandins\|\|Product Type\|Biochemicals\|Receptor Pharmacology\|Agonists\|\|Research Area\|Lipid Biochemistry\|Cyclooxygenase Pathway

搜索质检报告(COA)

相关产品

methyl (Z)-3-hydroxy-4-methylpent-2-enoate & methyl 4-methyl-3-oxopentanoate

Calcium (5R)-7-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl- 4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-5-hydroxy-3- methoxyheptanoate

((R)-7-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-3-hydroxy-5-oxoheptanoate) calcium(II)

tert-butyl (3S,5R)-7-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4- (phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoate

tert-butyl (3R,5S)-7-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4- (phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoate

tert-butyl (3R,5R)-7-((3R,5R)-7-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanamido)-3,5-dihydroxyheptanoate

(3R,5R)-tert-butyl 7-(2,3-bis(4-fluorophenyl)-5-isopropyl-4- (phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoate

((3R,5S)-7-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenyl carbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoate)calcium(II)

7-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H- pyrrol-1-yl)-5-hydroxy-3-oxoheptanoic acid sodium salt

(3R,5R)-tert-butyl3,5-dihydroxy-7-(2-isopropyl-4,5-diphenyl-3- (phenylcarbamoyl)-1H-pyrrol-1-yl)heptanoate